The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
- 1 May 2005
- journal article
- review article
- Published by Informa UK Limited in Expert Opinion on Biological Therapy
- Vol. 5 (5), 683-690
- https://doi.org/10.1517/14712598.5.5.683
Abstract
Interleukin (IL)-6 plays essential roles not only in the immune response, but also in haematopoiesis and the central nervous system. Deregulated production of IL-6 has been found in chronic inflammatory autoimmune diseases, such as rheumatoid arthritis (RA), systemic onset juvenile idiopathic arthritis (soJIA), Crohn’s disease (CD) and systemic lupus erythematosus (SLE). Furthermore, IL-6 activities can explain many symptoms of these diseases. More importantly, serum levels of IL-6 are correlated with disease activity. Based on these facts, the authors planned to develop a humanised anti-IL-6 receptor antibody, tocilizumab (previously known as MRA), as a therapeutic agent for these inflammatory autoimmune diseases. Tocilizumab is a neutralising antibody to suppress IL-6 signalling mediated by both membranous and soluble IL-6R. Clinical efficacy of tocilizumab in RA, soJIA, adult-onset Still’s disease or CD patients has been discussed in this review. In all of these diseases, tocilizumab has improved the disease activity, suggesting that IL-6 plays an essential role in the pathogenesis of these diseases.Keywords
This publication has 35 references indexed in Scilit:
- Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB × NZW)F1 hybridClinical Immunology and Immunopathology, 1992
- Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?Clinical and Experimental Immunology, 1991
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- The Molecular Regulators of Macrophage and Granulocyte DevelopmentAnnals of the New York Academy of Sciences, 1989
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988
- B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.The Journal of Experimental Medicine, 1988
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.The Journal of Experimental Medicine, 1988
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblastsEuropean Journal of Biochemistry, 1986